You are here

Multiple sclerosis

Cop 1 (Copaxone®): The Story of a Drug
01.05.1997

Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS

Prof. Ruth Arnon
28.01.1997
REHOVOT, Israel -- January 28, 1997 -- This week, two scientists from Israel's Weizmann Institute were honored for an...
New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee
19.09.1996
REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...
New Approach to Fighting Autoimmune Diseases
25.01.1996
REHOVOT, Israel -- January 25, 1996 -- A natural mechanism by which the body turns off inflammation...
Tuberculosis Bacteria May Protect Against Autoimmune Disease
01.10.1995

A protein derived from the tuberculosis bacterium might protect against multiple sclerosis

Pages